ChromaDex Corporation - Common Stock (CDXC)
5.5200
-0.1700 (-2.99%)
Chromadex Corp is a biotechnology company dedicated to developing and commercializing innovative dietary supplement products and ingredients that support health and wellness
It specializes in the research and development of natural products, particularly those derived from the compound known as nicotinamide riboside, which is believed to promote cellular health and longevity. Through its proprietary technologies and scientific expertise, Chromadex aims to provide consumers with solutions that enhance overall well-being and support healthy aging, while also collaborating with various partners to expand its product offerings and market reach.
Frequently Asked Questions
Is ChromaDex Corporation - Common Stock publicly traded?
Yes, ChromaDex Corporation - Common Stock is publicly traded.
What exchange does ChromaDex Corporation - Common Stock trade on?
ChromaDex Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for ChromaDex Corporation - Common Stock?
The ticker symbol for ChromaDex Corporation - Common Stock is CDXC on the Nasdaq Stock Market
What is the current price of ChromaDex Corporation - Common Stock?
The current price of ChromaDex Corporation - Common Stock is 5.520
When was ChromaDex Corporation - Common Stock last traded?
The last trade of ChromaDex Corporation - Common Stock was at 4:00 pm EST on February 7th, 2025
What is the market capitalization of ChromaDex Corporation - Common Stock?
The market capitalization of ChromaDex Corporation - Common Stock is 376.44M
How many shares of ChromaDex Corporation - Common Stock are outstanding?
ChromaDex Corporation - Common Stock has 68.20M shares outstanding.